Ipsen SA (IPN)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

€120.90

Buy

€121.80

arrow-down€-0.40 (-0.33%)

Prices updated at 12 Dec 2025, 16:35 CET

Prices minimum 15 mins delay

Prices in EUR

Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.

FTSE EuroFirst 300

-0.53%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	3,306m	3,575m
	2,735m	2,956m
	611m	688m
	18.49	19.25
	644m	346m
	1,007m	1,179m
Sales, General and administrative	1,135m	1,174m
Interest expenses	38m	42m
Provision for income taxes	136m	75m
Operating expenses	2,124m	2,268m
Income before taxes	762m	432m
Net income available to common shareholders	644m	346m
	7.79	4.18
Net interest income	-48m	-64m
Advertising and promotion	-	-
Net investment income, net	2m	5m
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	7.73	4.15
Free cash flow per share	9.1947	5.0832
Book value/share	41.1653	48.9291
Debt equity ratio	0.088128	0.09317

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	1,898m	2,021m
Current liabilities	1,627m	1,505m
Total capital	4,095m	4,469m
Total debt	306m	427m
Total equity	3,825m	4,182m
Total non current liabilities	-	-
Loans	270m	288m
Total assets	6,323m	6,439m
Total liabilities	-	-
Cash and cash equivalents	528m	678m
Common stock	83m	83m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	1,166m	520m
Cash dividends paid	-100m	-100m
	683m	133m
Investments (gains) losses	-1,072m	-677m
	520m	678m
Net income	-	-
	866m	916m
	-183m	-782m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.